About Acubiosys
Acubiosys is a company based in Hyderabad (India) founded in 2017 by Srinivas Maddi. Acubiosys offers products and services including Drug Repurposing Platform, Preclinical ADMET, Animal Efficacy Studies, Novel Drug Delivery Products, and Analytical Support Services. Acubiosys operates in a competitive market with competitors including Charles River Laboratories, Cytel, LabCorp, Precision Medicine Group and Frontage Laboratories, among others.
- Headquarter Hyderabad, India
- Founders Srinivas Maddi
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Acubiosys Private Limited
- Date of Incorporation 08 Feb, 2017
- Jurisdiction Hyderabad, Telangana, India
-
Annual Revenue
$96.24 K (USD)-5.82as on Mar 31, 2023
-
Net Profit
$10.78 K (USD)8.98as on Mar 31, 2023
-
EBITDA
$50.95 K (USD)6.81as on Mar 31, 2023
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Acubiosys
Acubiosys offers a comprehensive portfolio of products and services, including Drug Repurposing Platform, Preclinical ADMET, Animal Efficacy Studies, Novel Drug Delivery Products, and Analytical Support Services.
Enables repurposing of existing drugs for new treatments
Ensures drug safety and efficacy through rigorous studies
Validates therapies in preclinical models for effectiveness
Develops innovative systems for enhanced treatment delivery
Offers precise analysis for biotechnological solutions
Funding Insights of Acubiosys
Detailed funding history for Acubiosys
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Acubiosys
Investment portfolio details for Acubiosys
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Acubiosys
Detailed financials for Acubiosys
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Acubiosys Comparisons
Peer comparison for Acubiosys
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Acubiosys
Acubiosys operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Charles River Laboratories, Cytel, LabCorp, Precision Medicine Group and Frontage Laboratories, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of drug discovery and preclinical development services
|
|
| Locked | Locked | Locked |
Data analysis and statistical solutions are provided for life sciences.
|
|
| Locked | Locked | Locked |
Provider of laboratory tests for physicians
|
|
| Locked | Locked | Locked |
Provider of clinical research, development, and commercialization services for life sciences
|
|
| Locked | Locked | Locked |
Early drug development services are provided for pharma firms.
|
|
| Locked | Locked | Locked |
Cell line engineering services are offered via CRISPR-Cas9 technology.
|
Detailed competitors of Acubiosys
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Acubiosys
Complete news archive for Acubiosys
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Acubiosys
Acubiosys was founded in 2017.
Acubiosys is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
Srinivas Maddi is the current CEO of Acubiosys. They have also founded this company.
Annual revenue of Acubiosys is $96.24K as on Mar 31, 2023.
Acubiosys was established in 2017 in Hyderabad, India, as a research and development entity. Services are offered from early-stage discovery through to full drug development, targeting sectors such as pharmaceuticals, biotechnology, AYUSH, nutraceuticals, and medical devices. Operations support industrial needs across these areas with a structured approach to innovation and testing.
Acubiosys's top competitors include LabCorp, Charles River Laboratories and Cytel.
Acubiosys offers Drug Repurposing Platform, Preclinical ADMET, Animal Efficacy Studies, Novel Drug Delivery Products, and Analytical Support Services.